欢迎访问中国烧伤创疡杂志网站！

IIF-SSS 及 BP180、BP230 抗体检测在大疱性类天疱疮病情评估中的应用价值分析
Application Value of IIF-SSS and BP180 / BP230 Antibody Assay in Evaluating the Severity of Bullous Pemphigoid

王娟,张晨阳,朱伟红,于伟,倪文琼.IIF-SSS 及 BP180、BP230 抗体检测在大疱性类天疱疮病情评估中的应用价值分析[J].中国烧伤创疡杂志,2023,(2):158~163.

DOI：

中文关键词: 大疱性类天疱疮盐裂皮肤间接免疫荧光ＢＰ１８０ＢＰ２３０酶联免疫吸附法急性发作预测价值

英文关键词:Bullous pemphigoid Indirect immunofluorescence on salt-split skin BP180 BP230 Enzyme-linked immunosorbent assay Acute attack Predictive value

基金项目:河南省医学科技攻关计划项目 (2018020805)

作者	单位
王娟	450007 河南郑州，郑州大学附属郑州中心医院皮肤科
张晨阳
朱伟红
于伟
倪文琼

摘要点击次数: 1682

全文下载次数: 4248

中文摘要:

【摘要】目的分析盐裂皮肤间接免疫荧光 (IIF-SSS) 及大疱性类天疱疮 (BP) 180? BP230 抗体检测在BP 病情评估中的应用价值。方法选取 2018 年 7 月至 2020 年 7 月郑州大学附属郑州中心医院收治的 150 例 BP患者作为研究对象, 收集患者就诊时及就诊后第 30、60、180 天的 IIF-SSS 滴度、BP180 与 BP230 抗体水平、自身免疫性大疱性皮肤病严重程度评分 (ABSIS) 等资料, 并根据皮损消退后 6 个月内是否复发将其分为复发组与非复发组，分析 IIF-SSS 滴度以及 BP180、BP230 抗体水平与 ABSIS 的相关性及对 BP 复发的预测价值。结果 150例 BP 患者皮损消退后 6 个月内复发 58 例 (38.67% ), 设为复发组; 未复发 92 例 (61.33% ), 设为未复发组。就诊后第 30、60、180天, 复发组患者 IIF-SSS 滴度、BP180 与 BP230 抗体水平以及 ABSIS 均明显高于未复发组(就诊后第 30 天: t = 4.256、2.828、2.894、2.612, P < 0.001、P = 0.005、P = 0.004、P = 0.010; 就诊后第 60天: t = 3.959、10.080、5.312、3.182, P < 0.001、P < 0.001、P < 0.001、P = 0.002; 就诊后第 180 天: t =2.928、12.240、17.020、8.575, P = 0. 004、P < 0.001、P < 0.001、P < 0.001); Pearson 相关性分析结果显示,IIF-SSS 滴度以及 BP180、BP230 抗体水平与 ABSIS 均呈显著正相关性 ( r = 0.215、0.243、0.196, P = 0.008、0.003、0.016); 受试者工作特征 (ROC) 曲线分析结果显示, IIF-SSS 联合 BP180、BP230 抗体检测预测 BP 复发的曲线下面积 (AUC) 为 0.826, 敏感度为 81.7% , 特异度为 78.8%。结论 IIF-SSS 与 BP180、BP230 抗体检测能够有效评估 BP 患者病情严重程度, 对 BP 复发具有较高的预测价值。

英文摘要:

【Abstract 】 Objective To analyze the application value of indirect immunofluorescence on salt-split skin(IIF-SSS) and bullous pemphigoid ( BP) 180 / BP230 antibody assay in evaluating the severity of bullous pemphigoid(BP). Methods 150 BP patients, admitted to Zhengzhou Central Hospital Affiliated to Zhengzhou University from July2018 to July 2020, were enrolled as research subjects. Data including IIF-SSS titre, BP180 and BP230 antibody levels,autoimmune bullous skin disorder intensity score (ABSIS) were collected respectively on visit and on day 30, 60, and 180 after visit. The patients were divided into relapse group and non-relapse group based on whether BP re-occurred within 6months after the regression of skin lesions. The correlation of IIF-SSS titre and BP180 / BP230 antibody levels with ABSIS scores and the value in predicting BP relapse were analyzed. Results Among the 150 BP patients, 58 cases (38.67% )suffered BP relapse within 6 months after the regression of skin lesions, being set as the relapse group, and the other 92 cases (61.33% ) without the BP relapse within 6 months after the regression of skin lesions were set as the non-relapse group. On day 30, 60, and 180 after visit, the IIF-SSS titre, BP180 and BP230 antibody levels, and ABSIS scores of patients in the relapse group were all significantly higher compared with the non-relapse group ( day 30 after visit: t =4.256, 2.828, 2.894 and 2.612, P < 0.001, P = 0.005, P = 0.004, P = 0.010; day 60 after visit: t = 3.959, 10.080,5.312 and 3.182, P < 0.001, P < 0.001, P < 0.001, P = 0.002; day 180 after visit: t = 2.928, 12.240, 17.020 and 8.575, P = 0.004, P < 0.001, P < 0.001, P < 0.001). Pearson correlation analysis showed that IIF-SSS titre, BP180 and BP230 antibody levels were all positively correlated with ABSIS scores (r = 0.215, 0.243 and 0.196, P = 0.008, 0.003 and 0.016). The receiver operating characteristic ( ROC) curve showed that the area under the curve ( AUC) of IIF-SSS combined with BP180 / BP230 antibody assay in predicting BP relapse was 0.826, with the sensitivity being 81.7% and the specificity being 78.8% . Conclusion IIF-SSS and BP180 / BP230 antibody assay can effectively evaluate the severity of BP and have high value in predicting the recurrence of BP.